跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

安全信息

SML2308

Sigma-Aldrich

硫酸阿扎那韦 硫酸酯

≥95% (HPLC)

别名:

(3S,8S,9S,12S)-1,14-Dimethyl-3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioate sulfate

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C38H52N6O7 · H2SO4
CAS号:
229975-97-7
分子量:
802.93
UNSPSC代码:
12352200
NACRES:
NA.77

方案

≥95% (HPLC)

表单

powder

旋光性

[α]/D -40 to -50°, c = 1 in methanol: water (1:1)

储存条件

desiccated

颜色

white to beige

溶解性

H2O: 2 mg/mL, clear

运输

wet ice

储存温度

2-8°C

SMILES字符串

O[C@@H](CN(CC1=CC=C(C2=CC=CC=N2)C=C1)NC([C@@H](NC(OC)=O)C(C)(C)C)=O)[C@@H](NC([C@@H](NC(OC)=O)C(C)(C)C)=O)CC3=CC=CC=C3.O=S(O)OO

InChI

1S/C38H52N6O7.H2O4S/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28;1-5(2,3)4/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47);(H2,1,2,3,4)/t29-,30-,31+,32+;/m0./s1

InChI key

DQSGVVGOPRWTKI-QVFAWCHISA-N

正在寻找类似产品? 访问 产品对比指南

生化/生理作用

Atazanavir sulfate is the prodrug of Atazanavir, an antiviral HIV protease inhibitor.

象形图

Health hazardCorrosion
GHS08,GHS05

警示用语：

Danger

危险声明

H318,H372

危险分类

Eye Dam. 1 - STOT RE 1

靶器官

Heart,Liver

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

从最新的版本中选择一种：

分析证书(COA)

Lot/Batch Number
0000148155
0000148154
0000148154
0000148155
0000045283

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Jose R Castillo-Mancilla et al.
The Journal of antimicrobial chemotherapy, 71(6), 1609-1618 (2016-02-20)
The multinational PEARLS (ACTG A5175) study, conducted mainly in resource-limited settings, identified an increased treatment failure rate among HIV-infected individuals randomized to once-daily unboosted atazanavir, didanosine-EC, and emtricitabine compared with efavirenz-based regimens. We evaluated associations between selected human genetic polymorphisms
Vincent Calvez et al.
The Journal of antimicrobial chemotherapy, 72(1), 19-28 (2016-09-23)
For many patients living with HIV-1, the efficacy of combined ART (cART) has made the infection turn to a chronic disease. Because cART is associated with a risk of long-term toxicity, switching patients with virological success to another therapy remains
Lisa Rosenblatt et al.
BMC infectious diseases, 16, 492-492 (2016-09-20)
A previous cohort study indicated that atazanavir (ATV), a protease inhibitor used for HIV treatment, is not associated with an increased risk of cardiovascular (CV) events. The objective of this study was to compare the risk of CV events among

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门